ORBIMED ADVISORS LLC Q2 2019 Filing
Filed August 14, 2019
Portfolio Value
$6.5B
Holdings
123
Report Date
Q2 2019
Filing Type
13F-HR
All Holdings (123 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ASNDASCENDIS PHARMA A S | 3,846,673 | $442.9B | 6859.87% | |
| 2 | 1T7TRICIDA INC | 11,114,280 | $438.6B | 6792.11% | |
| 3 | BSXBOSTON SCIENTIFIC CORP | 6,752,500 | $290.2B | 4494.67% | |
| 4 | ALXNALEXION PHARMACEUTICALS INC | 1,926,085 | $252.3B | 3907.04% | |
| 5 | ALECALECTOR INC | 13,182,329 | $250.5B | 3878.93% | |
| 6 | MRKMERCK & CO INC | 2,570,100 | $215.5B | 3337.49% | |
| 7 | —PREVAIL THERAPEUTICS INC | 13,822,463 | $182.5B | 2825.71% | |
| 8 | VRTXVERTEX PHARMACEUTICALS INC | 973,300 | $178.5B | 2764.18% | |
| 9 | NBIXNEUROCRINE BIOSCIENCES INC | 1,833,200 | $154.8B | 2397.03% | |
| 10 | IOVAIOVANCE BIOTHERAPEUTICS INC | 5,548,326 | $136.0B | 2106.93% | |
| 11 | TMOTHERMO FISHER SCIENTIFIC INC | 462,800 | $135.9B | 2104.91% | |
| 12 | EWEDWARDS LIFESCIENCES CORP | 715,000 | $132.1B | 2045.66% | |
| 13 | SRPTSAREPTA THERAPEUTICS INC | 828,400 | $125.9B | 1949.43% | |
| 14 | —WRIGHT MED GROUP N V | 4,187,799 | $124.9B | 1934.02% | |
| 15 | ISRGINTUITIVE SURGICAL INC | 210,300 | $110.3B | 1708.42% | |
| 16 | —TURNING POINT THERAPEUTICS I | 2,567,550 | $104.5B | 1618.38% | |
| 17 | ELVANTHEM INC | 361,600 | $102.0B | 1580.40% | |
| 18 | BHCBAUSCH HEALTH COS INC | 3,740,700 | $94.3B | 1461.04% | |
| 19 | PTCTPTC THERAPEUTICS INC | 2,089,700 | $94.0B | 1456.35% | |
| 20 | INSPINSPIRE MED SYS INC | 1,471,000 | $89.2B | 1381.69% | |
| 21 | NTRANATERA INC | 3,224,328 | $88.9B | 1377.21% | |
| 22 | —LOGICBIO THERAPEUTICS INC | 6,466,783 | $84.1B | 1301.96% | |
| 23 | BMYBRISTOL MYERS SQUIBB CO | 1,845,200 | $83.7B | 1295.95% | Call |
| 24 | EX9EXELIXIS INC | 3,912,900 | $83.6B | 1295.01% | |
| 25 | —AVEDRO INC | 4,240,128 | $83.3B | 1289.69% | |
| 26 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 3,618,171 | $81.6B | 1263.58% | |
| 27 | ABTABBOTT LABS | 938,000 | $78.9B | 1221.71% | |
| 28 | EHTHEHEALTH INC | 909,814 | $78.3B | 1213.17% | |
| 29 | ATNXEURATHENEX INC | 3,840,130 | $76.0B | 1177.55% | |
| 30 | —SYNTHORX INC | 5,316,355 | $71.8B | 1112.34% | |
| 31 | QUREUNIQURE NV | 897,800 | $70.2B | 1086.61% | |
| 32 | MGTXMEIRAGTX HOLDINGS PLC | 2,586,951 | $69.5B | 1076.92% | |
| 33 | REGNREGENERON PHARMACEUTICALS | 215,800 | $67.5B | 1046.07% | |
| 34 | AG8AGILENT TECHNOLOGIES INC | 893,200 | $66.7B | 1032.90% | |
| 35 | —AUDENTES THERAPEUTICS INC | 1,713,069 | $64.9B | 1004.44% | |
| 36 | ARVNARVINAS INC | 2,678,810 | $58.9B | 912.29% | |
| 37 | —PRINCIPIA BIOPHARMA INC | 1,605,713 | $53.3B | 825.36% | |
| 38 | ILMNILLUMINA INC | 140,200 | $51.6B | 799.36% | |
| 39 | CRNXCRINETICS PHARMACEUTICALS IN | 2,039,282 | $51.0B | 789.56% | |
| 40 | —RESTORBIO INC | 4,830,387 | $49.3B | 763.04% | |
| 41 | APLSAPELLIS PHARMACEUTICALS INC | 1,898,700 | $48.1B | 745.14% | Call |
| 42 | —MYOKARDIA INC | 955,300 | $47.9B | 741.81% | |
| 43 | VRAYQVIEWRAY INC | 5,149,019 | $45.4B | 702.54% | |
| 44 | ARGXARGENX SE | 310,400 | $43.9B | 680.59% | |
| 45 | ZLABZAI LAB LTD | 1,169,000 | $40.8B | 631.30% | |
| 46 | NXTCNEXTCURE INC | 2,711,013 | $40.6B | 628.94% | |
| 47 | CICIGNA CORP NEW | 252,600 | $39.8B | 616.34% | |
| 48 | DC4DEXCOM INC | 262,900 | $39.4B | 610.08% | |
| 49 | TNDMTANDEM DIABETES CARE INC | 570,790 | $36.8B | 570.34% | |
| 50 | GILDGILEAD SCIENCES INC | 501,600 | $33.9B | 524.82% | Call |
| 51 | PRTAPROTHENA CORP PLC | 3,065,278 | $32.4B | 501.78% | |
| 52 | —HARPOON THERAPEUTICS INC | 2,446,409 | $31.8B | 492.53% | |
| 53 | TAKTAKEDA PHARMACEUTICAL CO LTD | 1,750,000 | $31.0B | 479.71% | Call |
| 54 | CDNACAREDX INC | 827,600 | $29.8B | 461.28% | |
| 55 | —OBSEVA SA | 2,605,531 | $29.5B | 456.39% | |
| 56 | SPYSPDR S&P 500 ETF TR | 100,000 | $29.3B | 453.77% | Put |
| 57 | CLVSEURCLOVIS ONCOLOGY INC | 1,913,234 | $28.4B | 440.60% | |
| 58 | XTNTXTANT MED HLDGS INC | 9,207,012 | $27.6B | 427.77% | |
| 59 | —MYLAN N V | 1,373,305 | $26.1B | 404.95% | |
| 60 | KRYSKRYSTAL BIOTECH INC | 642,006 | $25.9B | 400.40% | |
| 61 | —ENDO INTL PLC | 6,165,464 | $25.4B | 393.40% | |
| 62 | CRVSCORVUS PHARMACEUTICALS INC | 6,565,685 | $24.6B | 380.30% | |
| 63 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 1,960,200 | $23.3B | 360.96% | |
| 64 | AUPHAURINIA PHARMACEUTICALS INC | 3,531,002 | $23.2B | 359.82% | |
| 65 | —SPARK THERAPEUTICS INC | 219,900 | $22.5B | 348.66% | |
| 66 | AMGNAMGEN INC | 122,100 | $22.5B | 348.47% | |
| 67 | GNFTYGENFIT S A | 1,125,607 | $22.2B | 344.29% | |
| 68 | KALAKALA PHARMACEUTICALS INC | 3,447,840 | $22.0B | 340.67% | |
| 69 | ALCALCON INC | 351,380 | $21.7B | 335.79% | |
| 70 | BIIBBIOGEN INC | 87,700 | $20.5B | 317.64% | |
| 71 | SIBNSI BONE INC | 985,368 | $20.0B | 310.39% | |
| 72 | KPTIEURKARYOPHARM THERAPEUTICS INC | 3,148,475 | $18.9B | 292.07% | |
| 73 | —SYNLOGIC INC | 2,029,996 | $18.5B | 286.09% | |
| 74 | RYTMRHYTHM PHARMACEUTICALS INC | 787,300 | $17.3B | 268.25% | |
| 75 | VRCAVERRICA PHARMACEUTICALS INC | 1,479,733 | $17.2B | 266.28% | |
| 76 | NVONOVO-NORDISK A S | 330,000 | $16.8B | 260.85% | |
| 77 | SVASINOVAC BIOTECH LTD | 2,839,500 | $16.6B | 257.25% | |
| 78 | NVLSEURALPINE IMMUNE SCIENCES INC | 3,670,955 | $15.5B | 239.35% | |
| 79 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 2,165,524 | $14.8B | 229.73% | |
| 80 | ABBVABBVIE INC | 200,000 | $14.5B | 225.24% | Call |
| 81 | ASNSUSDX4 PHARMACEUTICALS INC | 936,493 | $14.0B | 217.55% | |
| 82 | AMRNAMARIN CORP PLC | 717,600 | $13.9B | 215.49% | |
| 83 | BMRNBIOMARIN PHARMACEUTICAL INC | 150,000 | $12.8B | 198.98% | Put |
| 84 | PRQRPROQR THRAPEUTICS N V | 1,382,502 | $12.6B | 194.84% | |
| 85 | —FOAMIX PHARMACEUTICALS LTD | 5,195,330 | $12.4B | 191.50% | |
| 86 | —IMMUNOMEDICS INC | 818,200 | $11.3B | 175.75% | |
| 87 | —NABRIVA THERAPEUTICS PLC | 4,644,600 | $11.3B | 174.79% | |
| 88 | SYKSTRYKER CORP | 54,000 | $11.1B | 171.92% | |
| 89 | —ARQULE INC | 1,000,000 | $11.0B | 170.51% | |
| 90 | SCPHSCPHARMACEUTICALS INC | 3,409,865 | $10.9B | 168.45% | |
| 91 | PFEPFIZER INC | 250,000 | $10.8B | 167.72% | Put |
| 92 | —CONSTELLATION PHARMCETICLS I | 835,842 | $10.3B | 158.96% | |
| 93 | RETAEURREATA PHARMACEUTICALS INC | 100,000 | $9.4B | 146.12% | Put |
| 94 | PSNLPERSONALIS INC | 300,000 | $8.1B | 126.14% | |
| 95 | PBYIPUMA BIOTECHNOLOGY INC | 624,249 | $7.9B | 122.87% | |
| 96 | —MERSANA THERAPEUTICS INC | 1,891,119 | $7.7B | 118.61% | |
| 97 | ASMBASSEMBLY BIOSCIENCES INC | 523,600 | $7.1B | 109.38% | |
| 98 | AM6AMICUS THERAPEUTICS INC | 518,309 | $6.5B | 100.17% | |
| 99 | ARNAEURARENA PHARMACEUTICALS INC | 110,000 | $6.4B | 99.88% | |
| 100 | VRNAVERONA PHARMA PLC | 1,250,396 | $6.4B | 98.76% |
Page 1 of 2Next